| Colonial Oaks Health Care Center | |
| 4725 S Colonial Oaks Dr, Marion, Indiana 46953 | |
| (765) 674-9791 | |
| Name | Colonial Oaks Health Care Center |
|---|---|
| Location | 4725 S Colonial Oaks Dr, Marion, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 127 |
| Occupancy Rate | 63.78% |
| Medicare ID (CCN) | 155289 |
| Legal Business Name | Riverview Hospital |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1033225669 |
| Organization Name | RIVERVIEW HOSPITAL |
| Doing Business As | COLONIAL OAKS HEALTH AND REHABILIATION CENTER |
| Address | 4725 S Colonial Oaks Dr, Marion, IN 46953 |
| Phone Number | 765-674-9791 |
News Archive
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
Bacteria acquired up to 90 percent of their genetic material from distantly related bacteria species, according to new research from The University of Arizona in Tucson.
An innovative program from UNC's Frank Porter Graham Child Development Institute (FPG) and 6 partner universities is preparing students with autism for life after high school.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
Bacteria acquired up to 90 percent of their genetic material from distantly related bacteria species, according to new research from The University of Arizona in Tucson.
An innovative program from UNC's Frank Porter Graham Child Development Institute (FPG) and 6 partner universities is preparing students with autism for life after high school.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $3250 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 15.84 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.56 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.67 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.8 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.37 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.88 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3.44 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.14 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.85 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 31.13 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.53 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.76 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.01 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.35 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 53.44 | 82.93 |
News Archive
Insys Therapeutics, Inc. today announced that the Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for Fentanyl SL Spray. The FDA will notify Insys of its PDUFA date in the 74-day letter which is expected in the upcoming weeks.
Bacteria acquired up to 90 percent of their genetic material from distantly related bacteria species, according to new research from The University of Arizona in Tucson.
An innovative program from UNC's Frank Porter Graham Child Development Institute (FPG) and 6 partner universities is preparing students with autism for life after high school.
Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the latest innovations in Phase I and IIa clinical trial designs.
› Verified 8 days ago
Colonial Oaks Health Care Center Location: 4725 S Colonial Oaks Dr, Marion, Indiana 46953 Phone: (765) 674-9791 | |